Q5105 - Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
100 UNITS |
0.839 |
- |
- |
- |
- |
- |
- |
|
|
Q5106 - Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
1000 UNITS |
8.395 |
- |
- |
- |
- |
- |
- |
|
|
Q5107 - Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
10 MG |
32.239 |
- |
- |
- |
- |
- |
- |
|
|
Q5108 - Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg |
0.5 MG |
165.268 |
- |
- |
- |
- |
- |
- |
|
|
Q5110 - Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram |
1 MCG |
0.34 |
- |
- |
- |
- |
- |
- |
|
|
Q5111 - Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
0.5 MG |
171.869 |
- |
- |
- |
- |
- |
- |
|
|
Q5112 - Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg |
10 MG |
68.497 |
- |
- |
- |
- |
- |
- |
|
|
Q5113 - Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg |
10 MG |
42.955 |
- |
- |
- |
- |
- |
- |
|
|
Q5114 - Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg |
10 MG |
47.803 |
- |
- |
- |
- |
- |
- |
|
|
Q5115 - Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
10 MG |
48.34 |
- |
- |
- |
- |
- |
- |
|
|
Q5116 - Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg |
10 MG |
45.48 |
- |
- |
- |
- |
- |
- |
|
|
Q5117 - Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg |
10 MG |
38.491 |
- |
- |
- |
- |
- |
- |
|
|
Q5118 - Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
10 MG |
41.862 |
- |
- |
- |
- |
- |
- |
|
|
Q5119 - Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg |
10 MG |
44.029 |
- |
- |
- |
- |
- |
- |
|
|
Q5120 - Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg |
0.5 MG |
153.333 |
- |
- |
- |
- |
- |
- |
|
|
Q5121 - Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
10 MG |
38.649 |
- |
- |
- |
- |
- |
- |
|
|
Q5122 - Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg |
0.5 MG |
217.685 |
- |
- |
- |
- |
- |
- |
|
|
Q5123 - Injection, rituximab-arrx, biosimilar, (riabni), 10 mg |
10 MG |
49.837 |
- |
- |
- |
- |
- |
- |
|
|
Q9950 - Injection, sulfur hexafluoride lipid microspheres, per ml |
1 ML |
18.492 |
- |
- |
- |
- |
- |
- |
|
|
Q9956 - Injection, octafluoropropane microspheres, per ml |
1 ML |
30.437 |
- |
- |
- |
- |
- |
- |
|
|
Q9957 - Injection, perflutren lipid microspheres, per ml |
1 ML |
45.656 |
- |
- |
- |
- |
- |
- |
|
|
Q9958 - High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml |
1 ML |
0.073 |
- |
- |
- |
- |
- |
- |
|
|
Q9961 - High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml |
1 ML |
0.247 |
- |
- |
- |
- |
- |
- |
|
|
Q9963 - High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
1 ML |
0.185 |
- |
- |
- |
- |
- |
- |
|
|
Q9965 - Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1 ML |
0.892 |
- |
- |
- |
- |
- |
- |
|
|